The medical world is seeing a significant shift in diabetes management with the arrival of GLP-1 patches. These systems offer a possibly more user-friendly alternative to shots of GLP-1 medications, lessening the frequency of daily needle pricks. The approach releases the drug directly through the epidermis, potentially enhancing patient participat